Last News

Besides following our news, follow us on socials networks :

TransCure bioServices involved in Targovax’s results 19 December 2018

Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.

Read more
TransCure will be waiting you at the second edition of I4ID 4 December 2018

Besides being present at I4ID event, Sébastien Tabruyn, our CSO, will give a pitch for answering one question : “How humanized mice models helps to evaluate immunotherapy for infectious Diseases?”

Read more
Acquisition of a second flow cytometer 13 November 2018

TransCure team has just acquired a second AttuneTM NxT Flow Cytometer. With this new cytometer, the scientific team will be able to carry out more accurate studies, analyze more sample types and expand its capabilities.

Read more
2018 Nobel Prize in Medicine, our CEO reacts! 8 November 2018

Patrick Nef, CEO at TransCure reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy.

Read more
TransCure bioServices (TCS) hired Antoine POSKIN, Veterinarian, PhD to manage the animal Facilities and get the AAALAC accreditation 5 November 2018
Read more
They talk about us in Labiotech 26 October 2018

Find more about TransCure humanized mice models which makes it possible to test novel anti-HIV treatments on infected animal models with a fully functional human immune system!

Read more